Pipeline-Haisco Pharmaceutical Group

Home > Innovative R&D > Pipeline

Innovative R&D Pipeline Platform

Pipeline

Drug Name

Target

Indications

IND

Clinical phase 1

Clinical phase 2

Clinical phase 3

NDA

Llisted

HSK42360

BRAF inhibitor (dimer breaker）

Solid Tumor

描述

NO

HSK46575

CYP11A1 inhibitor

Prostate Cancer

描述

NO

HSK41959

PRMT5-MTA inhibitor

Solid Tumor

描述

NO

HSK47977

Bcl-6 PROTAC

Lymphoma

描述

NO

HSK39297

CFB inhibitor

IgAN and PNH*

描述

NO

HSK31858**

DPP1 inhibitor

NCFBE***; Asthma

描述

NO

HSK44459

PDE4B inhibitor

IPF&PPF****; Psoriasis；Atopic Dermatitis

描述

NO

HSK47388

Oral IL-23R antagonist

Psoriasis and IBD*****

描述

NO

HSK31858

DPP1 inhibitor

NCFBE; Asthma

描述

NO

HSK44459

PDE4B inhibitor

IPF&PPF; Psoriasis；Atopic Dermatitis

描述

NO

HSK39004

PDE3/4 inhibitor (Nebulizer&DPI)

COPD; Asthma

描述

NO

HSK3486 (Cipepofol)

GABAa

Sedation and anesthesia in non-intubated surgery/procedures

Induction and maintenance of general anesthesia

ICU sedation

Induction of general anesthesia

描述

NO

HSK16149

VGCC

Diabetic peripheral neuropathic pain

Postherpetic neuralgia

描述

NO

HSK21542

KOR agonist iv

Postsurgical pain uremic pruritus PONV*

描述

NO

HSK36357

AAK1 inhibitor

Neuropathic Pain DMD**

描述

NO

HSK7653

Long acting DPP-4 inhibitor

Type II diabetes

Impaired glucose tolerance

描述

NO

HSK31679

THR-β agonist

EHC*; NASH

描述

暂无

HSK55879

GLP-1R agonist

Type II diabetes Obesity

描述

暂无